Olimel N9E inf. emuls. i.v.

Pays: Belgique

Langue: anglais

Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Ingrédients actifs:

Sodium Acetate Trihydrate 1,5 g/l; Sodium Glycerophosphate Hydrate - Eq. Sodium Glycerophosphate 3,67 mg/ml; Glycine 3,95 mg/ml; Glutamic Acid 2,84 mg/ml; Valine 3,64 mg/ml; Arginine 5,58 mg/ml; Leucine 3,95 mg/ml; Potassium Chloride 2,24 mg/ml; Magnesium Chloride Hexahydrate 0,81 mg/ml; Serine 2,25 mg/ml; Proline 3,4 mg/ml; Alanine 8,24 mg/ml; Lysine Acetate 6,32 g/l - Eq. Lysine 4,48 mg/ml; Histidine 3,4 mg/ml; Threonine 2,84 mg/ml; Tryptophan 0,95 mg/ml; Soyabean Oil + Olive Oil 40 mg/ml; Aspartic Acid 1,65 mg/ml; Glucose Monohydrate 121 mg/ml - Eq. Glucose Anhydrous 110 g/l; Calcium Chloride Dihydrate 0,52 g/l; Tyrosine 0,15 mg/ml; Isoleucine 2,84 mg/ml; Methionine 2,84 mg/ml; Phenylalanine 3,95 mg/ml

Disponible depuis:

Baxter SA-NV

Code ATC:

B05BA10

DCI (Dénomination commune internationale):

Tyrosine; Serine; Tryptophan; Methionine; Glucose Monohydrate; Sodium Acetate Trihydrate; Alanine; Lysine Acetate; Leucine; Arginine; Aspartic Acid; Proline; Glutamic Acid; Phenylalanine; Sodium Glycerophosphate Hydrate; Soyabean Oil + Olive Oil; Valine; Histidine; Magnesium Chloride Hexahydrate; Threonine; Isoleucine; Potassium Chloride; Glycine; Calcium Chloride Dihydrate

forme pharmaceutique:

Emulsion for infusion

Composition:

Tyrosine 0.15 mg/ml; Serine 2.25 mg/ml; Tryptophan 0.95 mg/ml; Methionine 2.84 mg/ml; Glucose Monohydrate 121 mg/ml; Sodium Acetate Trihydrate; Alanine 8.24 mg/ml; Lysine Acetate; Leucine 3.95 mg/ml; Arginine 5.58 mg/ml; Aspartic Acid 1.65 mg/ml; Proline 3.4 mg/ml; Glutamic Acid 2.84 mg/ml; Phenylalanine 3.95 mg/ml; Sodium Glycerophosphate Hydrate; Soyabean Oil + Olive Oil 40 mg/ml; Valine 3.64 mg/ml; Histidine 3.4 mg/ml; Magnesium Chloride Hexahydrate 0.81 mg/ml; Threonine 2.84 mg/ml; Isoleucine 2.84 mg/ml; Potassium Chloride 2.24 mg/ml; Glycine 3.95 mg/ml; Calcium Chloride Dihydrate

Mode d'administration:

Intravenous use

Domaine thérapeutique:

Combinations

Descriptif du produit:

CTI code: 370964-01 - Pack size: 4 x 2000 ml - Commercialisation status: YES - CNK code: 2786192 - Delivery mode: Medical prescription; CTI code: 370955-01 - Pack size: 4 x 1500 ml - Commercialisation status: YES - CNK code: 2786184 - Delivery mode: Medical prescription; CTI code: 370946-01 - Pack size: 6 x 1000 ml - Commercialisation status: YES - CNK code: 2786176 - Delivery mode: Medical prescription

Statut de autorisation:

Commercialised: Yes

Date de l'autorisation:

2010-06-04